ENDOPACK DT4-EBMCA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ENDOPACK DT4-EBMCA, covering 2025-05-25 to 2025-05-25. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Performance and Safety of ENDOPACK® DT4-EBMCA in ACL Reconstruction 24 Months Post-surgery : Post-market Clinical Follow-up Study [NA]